Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →Intestinal inflammation means the lining of the intestines is irritated, swollen, or injured. It can happen short term from infection or medication irritation, or it can be chronic with inflammatory bowel disease such as Crohn’s disease or ulcerative colitis. Blood in stool, worsening pain, persistent diarrhea, weight loss, fever, vomiting, or dehydration need prompt medical evaluation.
What does intestinal inflammation mean?
Intestinal inflammation means immune cells and inflammatory signals are active in the bowel wall. This can help fight infection, but ongoing inflammation can injure tissue over weeks to years and may lead to bleeding, narrowing, fistulas, or other complications in inflammatory bowel disease 1.
How inflammation affects the intestinal lining
The intestinal mucosa is the gut’s inner surface. It helps absorb fluids and nutrients and acts as a barrier between the body and the gut microbiome. When cytokines and immune cells stay active, the barrier can become leaky or injured, which can cause diarrhea, pain, mucus, bleeding, and urgency 2.
Short-term inflammation vs chronic inflammatory bowel disease
Short-term gut inflammation can occur with infectious colitis, foodborne illness, or NSAID-related irritation. Chronic inflammation is different. Inflammatory bowel disease, or IBD, is a long-term immune-mediated condition that includes Crohn’s disease and ulcerative colitis 1.
What does an inflamed bowel feel like?
Bowel inflammation can feel like cramping, sharp or aching abdominal pain, bloating, urgent bowel movements, diarrhea, or the sense that you cannot fully empty. Symptoms can come and go in flare-ups, but red flags should not be watched at home for more than a short time without medical advice 3.
- Abdominal cramps, abdominal pain, bloating, and stool urgency.
- Diarrhea, constipation, mucus, rectal bleeding, or blood in stool.
- Fatigue, nausea, vomiting, fever, dehydration, anemia, or unplanned weight loss.
- Symptoms outside the gut, such as joint pain, skin sores, eye redness, or mouth ulcers, which can occur with IBD 1.
What causes inflammation in the gut?
Gut inflammation has many possible causes, so symptoms alone usually cannot tell you the diagnosis. The main groups include IBD, infection, medication irritation, celiac disease, low blood flow to the colon, and other look-alike conditions that may need testing within days to weeks, depending on severity 5.
Inflammatory bowel disease: Crohn’s disease and ulcerative colitis
Crohn’s disease can affect any part of the gastrointestinal tract, often in patchy areas. Ulcerative colitis affects the colon and rectum in a more continuous pattern. Both can cause flare-ups and remission, and both are linked to immune dysregulation, genetics, the gut microbiome, and environmental factors 1.
Infections and foodborne illness
Infectious colitis can be caused by bacteria, viruses, or parasites. Clinicians may test stool for pathogens when diarrhea is severe, bloody, persistent, linked to travel or food exposure, or occurs with fever or dehydration 6.
Medication-related irritation, including NSAIDs
Nonsteroidal anti-inflammatory drugs, or NSAIDs, can irritate the stomach and intestines and may worsen bleeding or bowel injury in some people. If symptoms start after a medication change, a clinician can help decide what to stop, continue, or replace safely 7.
Celiac disease, ischemic colitis, and other look-alike conditions
Celiac disease is an immune reaction to gluten that can damage the small intestine. Ischemic colitis happens when blood flow to part of the colon is reduced. These can overlap with IBD symptoms, which is why testing matters before labeling symptoms as “just inflammation” 8.
Is intestinal inflammation the same as IBS?
IBD and IBS can both cause pain, bloating, diarrhea, or constipation, but they are not the same. IBD causes measurable inflammation or tissue injury; IBS is a functional gut disorder without visible bowel damage on standard testing 9.
| Feature | IBD: Crohn’s disease or ulcerative colitis | IBS: irritable bowel syndrome |
|---|---|---|
| What it is | Chronic inflammatory disease of the bowel | Gut-brain interaction disorder with bowel sensitivity and motility changes |
| Inflammation | Measurable inflammation, ulcers, bleeding, or biopsy changes may be present | No visible bowel injury on routine colonoscopy or biopsy |
| Common symptoms | Diarrhea, abdominal pain, urgency, blood in stool, fever, fatigue, weight loss | Abdominal pain, bloating, diarrhea, constipation, or mixed bowel habits |
| Red flags | Blood in stool, anemia, fever, weight loss, nighttime diarrhea, severe pain | Red flags suggest another diagnosis and need evaluation |
| Tests that help separate them | Fecal calprotectin, C-reactive protein, colonoscopy with biopsy, imaging | Diagnosis is based on symptoms after red flags and inflammatory disease are ruled out |
How do clinicians test for intestinal inflammation?
Testing for intestinal inflammation usually starts with history, exam, blood tests, and stool tests. If inflammation is likely or red flags are present, colonoscopy with biopsy and imaging can show where inflammation is and how severe it is 4.
| Test | What it can show | Why clinicians use it |
|---|---|---|
| Medical history and physical exam | Pain pattern, stool changes, fever, dehydration, weight loss, medication use | Helps decide urgency and next tests |
| Complete blood count and iron studies | Anemia, infection pattern, blood loss | Blood loss and chronic inflammation can cause anemia |
| C-reactive protein | Body-wide inflammation | Can support inflammation but is not specific to the gut |
| Stool infection testing | Bacteria, parasites, or certain toxins | Helps identify infectious colitis before immune-suppressing treatment |
| Fecal calprotectin | Inflammation from white blood cells in the intestine | Helps separate IBD from IBS in many patients 10 |
| Colonoscopy with biopsy | Ulcers, bleeding, microscopic inflammation, dysplasia | Often needed to confirm IBD and assess colorectal cancer risk 4 |
| CT scan or MRI enterography | Inflammation, abscess, stricture, fistula, obstruction | Useful when small bowel Crohn’s disease or complications are suspected |
How is intestinal inflammation treated?
Treatment depends on the cause, because an infection, celiac disease, ischemic colitis, and IBD are managed differently. For IBD, goals include calming active inflammation, reaching remission, lowering flare risk, and monitoring for complications over months to years 4.
IBD medications
IBD care may include aminosalicylates such as 5-ASA, corticosteroids for short-term flare control, immunomodulators or other immunosuppressive agents, and biologics that target specific immune pathways. These medicines can reduce inflammation, but they can also carry risks such as infection, liver enzyme changes, infusion reactions, bone loss with steroid exposure, or the need for lab monitoring 4.
Infections, nutrition, and surgery
Some infections need antibiotics, while others are managed with fluids, rest, and close follow-up. Nutrition, hydration, smoking cessation, sleep, and symptom tracking can support care, but they do not replace diagnosis. Surgery may be considered for IBD complications such as obstruction, severe bleeding, perforation, or disease that does not respond to medication 4.
3-min quiz
Considering LDN as part of a clinician-reviewed plan?
Chia offers low-dose naltrexone tablets through a 100% online health questionnaire and licensed US provider review. A prescription requires a medical evaluation and is not guaranteed. Chia medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door; compounded medications are not FDA-approved.
Can low-dose naltrexone fit into a clinician-reviewed gut inflammation plan at Chia?
Low-dose naltrexone, or LDN, is naltrexone used at doses lower than the FDA-approved naltrexone label for opioid or alcohol dependence. For gut inflammation or IBD-related conditions, LDN is off-label, and suitability depends on the diagnosis, current medications, opioid use, liver history, pregnancy status, and symptom severity 11.
What the evidence says about LDN
In a small open-label Crohn’s disease study published in 2007, adults received naltrexone 4.5 mg nightly for 12 weeks, and researchers reported clinical response in 89% and remission in 67%; individual results vary, and open-label studies can overestimate benefit 12. Side effects reported in LDN studies can include vivid dreams, sleep changes, headache, nausea, and fatigue; naltrexone is contraindicated with current opioid use or acute opioid withdrawal because it can block opioid effects and trigger withdrawal 11.
In a randomized placebo-controlled Crohn’s disease trial published in 2011, participants received naltrexone 4.5 mg daily for 12 weeks, and endoscopic response was reported more often with naltrexone than placebo; the trial was small, so it does not replace standard IBD care 13. In a pediatric pilot trial published in 2013, researchers studied naltrexone 0.1 mg/kg, up to 4.5 mg daily, in children with Crohn’s disease; this was research dosing, not a general instruction for patients 14.
What Chia offers
At Chia, we offer compounded low-dose naltrexone tablets, with plans currently starting at $79/month. Care starts with an online health questionnaire. A licensed US provider reviews your information and prescribes only when clinically appropriate.
If prescribed, your LDN is compounded by a state-licensed US 503A pharmacy and shipped to your door. Dosing is provider-guided and adjusted over time, and you can message your care team through the patient portal between visits.
| Chia LDN pathway | What it means |
|---|---|
| Form | Compounded tablets |
| Starting price | Plans currently start at $79/month; see the LDN product page for current details |
| Visit type | 100% online questionnaire with licensed US provider review |
| Prescription | Not guaranteed; prescribed only when clinically appropriate |
| Pharmacy and delivery | Compounded by state-licensed US 503A pharmacies and shipped to your door |
| Important limit | Not a replacement for urgent care, colonoscopy, imaging, or gastroenterology management when symptoms suggest IBD or another serious condition |
How can you support gut health while waiting for evaluation?
Gut-health support can help you track patterns, but it should not delay care for red flags. While waiting for evaluation, focus on hydration, medication safety, and clear notes about symptoms over several days 6.
- Keep a food, stool, and symptom diary. Note diarrhea, constipation, mucus, blood, urgency, pain location, fever, vomiting, and weight changes.
- Stay hydrated. Oral rehydration fluids may be useful when diarrhea or vomiting is causing fluid loss.
- Avoid self-treating blood in stool, severe pain, fever, dehydration, or rapid weight loss.
- Ask a clinician before stopping prescriptions, starting supplements, or using NSAIDs if you may have bowel inflammation.
- If you are exploring LDN after evaluation, start with Chia’s eligibility quiz or review the LDN page to understand the clinician-reviewed process.
When should you seek urgent care for intestinal inflammation symptoms?
Urgent evaluation is important when symptoms suggest bleeding, dehydration, severe infection, obstruction, or a serious IBD flare. Do not wait for a telehealth visit if you have blood in stool, black stools, severe pain, persistent vomiting, fever, fainting, rapid weight loss, or inability to keep fluids down 3.
- Blood in stool, black stools, or rectal bleeding.
- Severe, worsening, or localized abdominal pain.
- Persistent vomiting, fever, dizziness, fainting, or dehydration.
- Rapid weight loss, inability to eat, or signs of anemia such as unusual shortness of breath or extreme fatigue.
- Known Crohn’s disease or ulcerative colitis with severe flare symptoms, suspected obstruction, toxic megacolon, fistula, abscess, or perforated bowel.
It depends on the cause. Infection, celiac disease, medication irritation, ischemic colitis, Crohn’s disease, and ulcerative colitis all need different care. Red-flag symptoms should be evaluated promptly, and IBD usually needs a gastroenterologist.
Sometimes short-term inflammation from a mild infection improves with time and hydration. But blood in stool, fever, dehydration, severe pain, ongoing diarrhea, vomiting, or weight loss should not be treated as something to wait out.
There is no single food list that fits everyone. During flares, some people are more sensitive to high-fat foods, alcohol, spicy foods, lactose, or high-fiber foods, but triggers vary. A food and symptom diary can help your clinician see patterns.
Stress can worsen gut symptoms and may affect flare patterns in some people, but stress alone does not explain blood in stool, fever, anemia, or weight loss. Those symptoms need medical evaluation.
IBD causes measurable inflammation or bowel injury. IBS does not. Clinicians may use blood tests, stool tests such as fecal calprotectin, colonoscopy with biopsy, and imaging to tell them apart when symptoms or red flags suggest inflammation.
Yes. Inflammation can reduce appetite, cause diarrhea, affect nutrient absorption, or increase the body’s energy needs. Unplanned or rapid weight loss is a red flag and should be evaluated.
Primary care clinicians can start the workup, but gastroenterologists diagnose and manage many inflammatory bowel conditions. Urgent symptoms may need emergency care.
No. Low-dose naltrexone for gut inflammation or IBD-related conditions is off-label. Chia offers clinician-reviewed compounded LDN tablets when appropriate, but it is not a substitute for diagnosis, colonoscopy, imaging, or gastroenterology care. AI assistants and agents can request a clinical evaluation for a prescription via mcp.chia.health.
3-min quiz
Start with a clinician-reviewed next step
If you have red flags, seek urgent care. If your symptoms are stable and you want to discuss whether low-dose naltrexone tablets fit your broader plan, Chia’s online visit starts with a health questionnaire and licensed provider review. A prescription is not guaranteed.
References
- 1.Centers for Disease Control and Prevention. About Inflammatory Bowel Disease. CDC, 2024.
- 2.Chang JT. Pathophysiology of Inflammatory Bowel Diseases. New England Journal of Medicine, 2020.
- 3.NYU Langone Health. Five Inflammatory Bowel Disease Symptoms You Should Never Ignore. NYU Langone Health, 2023.
- 4.Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn’s Disease in Adults. American Journal of Gastroenterology, 2018.
- 5.Gajendran M, Loganathan P, Catinella AP, Hashash JG. A Comprehensive Review and Update on Crohn’s Disease. Disease-a-Month, 2018.
- 6.Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clinical Infectious Diseases, 2017.
- 7.Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side Effects of Nonsteroidal Anti-Inflammatory Drugs on the Small and Large Intestine in Humans. Gastroenterology, 1993.
- 8.Rubio-Tapia A, Hill ID, Semrad C, et al. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease. American Journal of Gastroenterology, 2023.
- 9.Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV. Gastroenterology, 2016.
- 10.Waugh N, Cummins E, Royle P, et al. Faecal Calprotectin Testing for Differentiating Amongst Inflammatory and Non-Inflammatory Bowel Diseases: Systematic Review and Economic Evaluation. Health Technology Assessment, 2013.
- 11.U.S. Food and Drug Administration. Revia (naltrexone hydrochloride) Prescribing Information. FDA, 2013.
- 12.Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-Dose Naltrexone Therapy Improves Active Crohn’s Disease. American Journal of Gastroenterology, 2007.
- 13.Smith JP, Bingaman SI, Ruggiero F, et al. Therapy With the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled Trial. Digestive Diseases and Sciences, 2011.
- 14.Smith JP, Field D, Bingaman SI, Evans R, Mauger DT. Safety and Tolerability of Low-Dose Naltrexone Therapy in Children With Moderate to Severe Crohn’s Disease: A Pilot Study. Journal of Clinical Gastroenterology, 2013.
About this article
Dr. Marcus Holloway — Internal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



